James G. Nichols
Founder and President
Jim spent over 40 years in the Medical Device and Laboratory Instrument Industry, spending multiple years in the areas of blood gases/blood chemistry, peritoneal dialysis, prostate and breast cancer, vision assessment and correction, and cardiac assessment and emergency life saving(CPR) apparatus, as well as the past 10 years in nutrition and wellness. He has held management positions at Corning Glass Works, VWR Scientific, was a member of The Office of the President of American Optical Corporation, President of Foster Medical Corporation, President of Microwave Medical Corporation. In addition to his founding, growing and developing Brunswick Laboratories LLC, he also founded Medical Products Mfg. LLC, a manufacturer of CPR and emergency lifesaving apparatus whose markets are primarily Japan and China. He was Vice-Chairman and Director of Nano-C, Inc., a high tech company developing uses for high quality carbon nanotubes and fullerenes.
Jim attended Vanderbilt University and received his B.S Degree in Biology and Chemistry from Valdosta State University. He is a native of Valdosta, Georgia and an U.S. Army Officer during the Viet Nam War.
Jin Ji, PhD, MA/Management
Chief Technology Officer & Executive Vice President
Dr. Jin Ji is a creative technology business leader focusing on identification and development of advanced technologies in nutraceutical, food, biomedical, and nanotechnology industries. Having gone through all stages of a commercial product and service from an idea on a piece of napkin, to raising venture funding, through R&D to service and products, Dr. Ji brings with her expertise in technology development, business operation, and market identification in the high tech industry in the United States.
At Brunswick Labs, Dr. Ji leads operation, marketing, and technology development. Dr. Ji is also a Co-founder and Chief Science Officer of Lightwave Power, Inc., a venture-backed US private nanotechnology company. Earlier in her career, Dr. Ji served as a Research Faculty at Harvard Medical School, and has 15+ years of experience in technology commercialization effort for a number of leading international institutes including Smith Group PLC (London Stock Exchange: SMIN), Harvard Medical School, and Harvard Institute of Proteomics.
Born in Shanghai, China, Dr. Ji holds PhD in BioAnalytical Chemistry from University of New Orleans and Masters in Management from Harvard University. She has authored over 30 patents, publications and proposals in the field of nutraceutial, biomedical, nano-optics, and renewable energy. Jin has lived and worked in US, Singapore, Germany, and China, and is well versed in both western and eastern cultures, business environments and markets.
Ronald L. Prior, PhD
Dr. Ron Prior is a scientific leader in nutraceutical industry who has focused on health effects of dietary fruits and vegetables for the past 30 years. His work in developing analytical techniques to quantitate phytochemicals in fruits and vegetables led to the expansion of the flavonoid database in the USDA Food Nutrient Database with the addition of data on anthocyanins, proanthocyanidins and antioxidant capacity (ORACFL). This has provided the first comprehensive set of phytonutrient data in commonly consumed foods in the U.S., and has made it possible to compute dietary intakes of these phytochemicals in several epidemiology and other clinical studies. Furthermore, Dr. Prior’s research has provided leadership in understanding the metabolism of anthocyanins and proanthocyanidins during the absorption process and the phenolic acids and other metabolites that are produced in the gastrointestinal tract as a result of microbial metabolism.
Dr. Prior has published more than 220 articles in peer reviewed scientific journals and has served on the editorial board of the Molecular Nutrition and Food Research and of the Journal of Agriculture and Food Chemistry and as a reviewer for a number of scientific journals. In 2006, Dr. Prior received the Alex Wetherbee Award from the North American Blueberry Council for his contributions to the blueberry industry. In 2012 received the James Joseph Research Award from the Highbush Blueberry Council in recognition of his research on fruits and vegetables. In 2006, Dr. Prior was ranked as the top-cited author in agricultural sciences by Science Watch during the period of 1999-2006, and he is coauthor on a classic paper (“The Chemistry Behind Antioxidant Capacity Assays”) which has been highlighted in Science Watch in 2008, 2009, 2010, and 2011.
Dr. Prior received his Ph.D. in Nutrition and post-doctoral training in Comparative Gastroenterology from Cornell University.
Lawrence Kaufman, PhD
Vice President, Business Development
Dr. Kaufman is a successful business leader with CEO, COO and Director experience in a wide variety of technology-based firms. Prior to Brunswick Labs, he was a director of MEMSIC, Inc., a public company selling MEMS-based systems and with operations in Wuxi, China. He was also a co-founder, CEO and director of Sionex Corporation, an early-stage company producing proprietary Ion Mobility Mass Spectrometry based chemical analyzer, a partner and advisor to The Pinnacle Acquisition Group, a private firm that acquired underperforming technology companies to renew them and was also a Director of The MicroOptical Corporation, now called MyVu Corporation, which developed virtual display glasses now being introduced by Google, Inc.
Prior to this he was a Director of Physical Sciences, Inc., Vice President, Operations, for Separation Technologies, Inc., President of A.C. Allen & Company, Inc. and an advisor to A/F Protein Inc. He was President & COO and Director of Tropix, Inc. and President & CEO of Psychemedics Corporation, a publicly held company.
He was graduated from Rensselaer Polytechnic Institute with a B.S. Physics degree and from Tufts University with a Ph.D. Solid State Physics degree. His education includes an Executive Development Certification from Yale University and a Masters Level Professional Director Certification from the American College of Corporate Directors, a national public company director education and credentialing organization.
Jun Xian, PhD
Dr. Jun Xian leads Brunswick Laboratories' technical services in biological, clinical and pharmaceutical applications. Dr. Xian is also the Founder and President of New Era Pharma (NEP), a contract research organization (CRO) specializing in early drug discovery analytical services for biotech and pharmaceutical industries. Prior to Brunswick Labs, Dr. Xian served as the Associate Director of Partner Center for Drug Discovery at Brigham and Women’s Hospital, a Harvard Medical School-affiliated hospital, and Assistant Director of Cancer Drug Discovery at Dana-Farber/Harvard Cancer Center. Dr. Xian participated in building two drug discovery programs in Harvard and its affiliated hospitals, and completed more than 30 projects.
Dr. Xian obtained his PhD in Chemistry from Wichita State University and completed his postdoctoral training in Biology from California Institute of Technology. He has 25+ years of experience in drug discovery and has built multiple drug discovery platforms. He is an expert in early drug discovery from target validation, biological assay design, HTS (high throughput screening), lead optimization, animal studies, to clinical studies.